PMC5448866_01
Patient 1 progress chart.
10.1177_2050313X17710594-fig1.jpg
PMC5448866_03_10.1177_2050313X17710594-fig1.jpg
fig1-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
Patient 2 progress chart.
10.1177_2050313X17710594-fig2.jpg
PMC5448866_03_10.1177_2050313X17710594-fig2.jpg
fig2-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
PMC5448866_02
Patient 1 progress chart.
10.1177_2050313X17710594-fig1.jpg
PMC5448866_03_10.1177_2050313X17710594-fig1.jpg
fig1-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
Patient 2 progress chart.
10.1177_2050313X17710594-fig2.jpg
PMC5448866_03_10.1177_2050313X17710594-fig2.jpg
fig2-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
PMC5448866_03
Patient 1 progress chart.
10.1177_2050313X17710594-fig1.jpg
PMC5448866_03_10.1177_2050313X17710594-fig1.jpg
fig1-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
Patient 2 progress chart.
10.1177_2050313X17710594-fig2.jpg
PMC5448866_03_10.1177_2050313X17710594-fig2.jpg
fig2-2050313X17710594
AOM 300 received brachial injections at 4-week intervals, alternating the left and right sides. 24 weeks after switching from oral low-dose aripiprazole to AOM, the following characteristics improved: PANSS total score (52 to 47), positive score (11 to 10), negative score (13 to 11), general score (28 to 26), QLS total score (97 to 106), and DIEPSS (4 to 2) (Figure 1, Table 2).
Patient 3 progress chart.
10.1177_2050313X17710594-fig3.jpg
PMC5448866_03_10.1177_2050313X17710594-fig3.jpg
fig3-2050313X17710594
The third outpatient was a 26-year-old man with paranoid schizophrenia who experienced akathisia under aripiprazole treatment (6 mg; Figure 3).